142 related articles for article (PubMed ID: 19260117)
1. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
Lundberg M; Pajusto M; Koskinen WJ; Mäkitie AA; Aaltonen LM; Mattila PS
Head Neck; 2009 May; 31(5):664-72. PubMed ID: 19260117
[TBL] [Abstract][Full Text] [Related]
2. [The association between polymorphism of transforming growth factor-β1 and radiochemotherapy response and survival in esophageal squamous cell carcinoma patients].
Zhou YL; Zhang WC; Chen XB; Xiao ZF; Qiao Y; Yu DK; Lin DX; Tan W
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):583-7. PubMed ID: 22041558
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
6. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
[TBL] [Abstract][Full Text] [Related]
7. TGFbeta1 genetic polymorphism is associated with survival in head and neck squamous cell carcinoma independent of the severity of chemoradiotherapy induced mucositis.
Lundberg M; Saarilahti K; Mäkitie AA; Mattila PS
Oral Oncol; 2010 May; 46(5):369-72. PubMed ID: 20308003
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
10. Association and treatment response to capecitabine-based chemoradiotherapy with CYP2C9 polymorphism in head and neck cancer.
Paul S; Pant MC; Parmar D; Verma J
Indian J Cancer; 2011; 48(2):223-9. PubMed ID: 21768671
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
12. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
13. TGFB1 promoter polymorphism C-509T and pathophysiology of asthma.
Ueda T; Niimi A; Matsumoto H; Takemura M; Yamaguchi M; Matsuoka H; Jinnai M; Chin K; Minakuchi M; Cheng L; Shirakawa T; Mishima M
J Allergy Clin Immunol; 2008 Mar; 121(3):659-64. PubMed ID: 18036644
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis.
Mattey DL; Nixon N; Dawes PT; Kerr J
Ann Rheum Dis; 2005 Aug; 64(8):1190-4. PubMed ID: 15695537
[TBL] [Abstract][Full Text] [Related]
15. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
[TBL] [Abstract][Full Text] [Related]
16. Influence of cytokine gene polymorphisms on IgA nephropathy.
Bantis C; Heering P; Aker S; Kuhr N; Grabensee B; Ivens K
Ren Fail; 2008; 30(2):135-40. PubMed ID: 18300111
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms.
van der Paardt M; Crusius JB; García-González MA; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
Ann Rheum Dis; 2005 Apr; 64(4):616-9. PubMed ID: 15769917
[TBL] [Abstract][Full Text] [Related]
19. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity.
González-Zuloeta Ladd AM; Arias-Vásquez A; Siemes C; Coebergh JW; Hofman A; Witteman J; Uitterlinden A; Stricker BH; van Duijn CM
Eur J Cancer; 2007 Jan; 43(2):371-4. PubMed ID: 17035001
[TBL] [Abstract][Full Text] [Related]
20. Interaction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma.
Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Yamashita H; Hinoda Y
Mol Carcinog; 2006 May; 45(5):344-8. PubMed ID: 16381036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
